Bio-Techne (MEX:TECH) Interest Expense: MXN-177 Mil (TTM As of Mar. 2026)


MEX:TECH Bio-Techne Corp MEX:TECH
83 GF Score
Price MXN1,090.00
GF Value MXN1,118.39
! 8 Warning Signs
View Full Analysis

What is Bio-Techne Interest Expense?

Bio-Techne MEX:TECH 83 Interest Expense is MXN-177 Mil as of Mar. 2026. GuruFocus rates MEX:TECH with a GF Score™ of 83/100 and a GF Value™ of MXN1,118.39. The stock has 8 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Bio-Techne's interest expense for the three months ended in Mar. 2026 was MXN -43 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was MXN-177 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Bio-Techne's Operating Income for the three months ended in Mar. 2026 was MXN 1,361 Mil. Bio-Techne's Interest Expense for the three months ended in Mar. 2026 was MXN -43 Mil. Bio-Techne's Interest Coverage for the quarter that ended in Mar. 2026 was 31.43. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Bio-Techne  (MEX:TECH) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bio-Techne's Interest Expense for the three months ended in Mar. 2026 was MXN-43 Mil. Its Operating Income for the three months ended in Mar. 2026 was MXN1,361 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was MXN4,980 Mil.

Bio-Techne's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*1361.379/-43.315
=31.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Bio-Techne Interest Expense Historical Data

* Premium members only.

The historical data trend for Bio-Techne's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Techne Interest Expense Chart

Bio-Techne Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -277.73 -227.51 -192.27 -288.29 -160.22

Bio-Techne Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -41.06 -41.01 -53.82 -39.09 -43.32
MEX:TECH
83GF Score
Bio-Techne Corp MEX:TECH
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio-Techne Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-177 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of MXN-177 Mil mean?
Bio-Techne (MEX:TECH) has a Interest Expense of MXN-177 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Bio-Techne and its competitors.
Is Bio-Techne's Interest Expense too high?
Bio-Techne's current Interest Expense is MXN-177 Mil. Overall, Bio-Techne has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Bio-Techne's Interest Expense compare to ARWR and CYTK?
Bio-Techne's Interest Expense of MXN-177 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Bio-Techne and its competitors. Bio-Techne's current Interest Expense is MXN-177 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Techne stock overvalued right now?
Bio-Techne (MEX:TECH) has a current Interest Expense of MXN-177 Mil. The stock's GF Value™ is MXN1,118.39, compared to a current price of MXN1,090.00 — trading 2.5% below its estimated fair value. The current Interest Expense is MXN-177 Mil. Bio-Techne's overall GF Score™ is 83/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Bio-Techne (MEX:TECH), the current Interest Expense is MXN-177 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio-Techne (MEX:TECH) Overvalued in 2026?

Based on GuruFocus' analysis, Bio-Techne stock appears to be undervalued. The current stock price of MXN1,090.00 is trading 2.5% below its estimated GF Value™ of MXN1,118.39.

Key valuation signals for MEX:TECH:

  • Interest Expense: MXN-177 Mil
  • GF Value™: MXN1,118.39 vs. price of MXN1,090.00 (2.5% below fair value)
  • GF Score™: 83/100 with 8 warning signs

No single metric tells the full story. See the MEX:TECH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bio-Techne Business Description

Address 614 McKinley Place N.E., Minneapolis, MN, USA, 55413
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
83GF Score

Get the complete analysis for MEX:TECH

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,090.00
Price
MXN1,118.39
GF Value